Pharmacogenomics is the research of how genes influence a person’s reaction to drugs. This comparatively new area brings together pharmacology and genomics to create efficient, safe drugs and doses that will be customized to a person’s genetic make-up. Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks into” the market or society.
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Short Communication: Pharmacoeconomics: Open Access
Short Communication: Pharmacoeconomics: Open Access
Review Article: Pharmacoeconomics: Open Access
Review Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Case Report: Pharmacoeconomics: Open Access
Case Report: Pharmacoeconomics: Open Access
Keynote: Journal of Bioanalysis & Biomedicine
Keynote: Journal of Bioanalysis & Biomedicine
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters: Journal of Bioanalysis & Biomedicine
Posters: Journal of Bioanalysis & Biomedicine
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report